Pharmacological interventions for non-ulcer dyspepsia - Wikidata - awgldk - TriplyDB

Pharmacological interventions for non-ulcer dyspepsia

Pharmacological interventions for non-ulcer dyspepsia

http://www.wikidata.org/entity/Q24244245

about

Prokinetics for functional dyspepsia Review article: current treatment options and management of functional dyspepsia Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study.Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.Functional dyspepsia.Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells Asian consensus report on functional dyspepsia.Burden of dyspepsia in rural and urban Asia.Proton pump inhibitors for functional dyspepsia.Assessing multiple medication use with probabilities of benefits and harms.Current and emerging therapies for the management of functional gastrointestinal disorders.A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori-Negative Primary Care Patients with Dyspepsia in Japan.Effect of acupuncture and its influence on cerebral activity in functional dyspepsia patients: study protocol for a randomized controlled trial.Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study.The role of Helicobacter pylori infection in functional dyspepsia Acupuncture for functional dyspepsia: study protocol for a two-center, randomized controlled trial.Epidemiology, approach and management of functional dyspepsia in Thailand.Acid peptic diseases: pharmacological approach to treatment.Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care.Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.Effects of a Herbal Medicine, Yukgunja-Tang, on Functional Dyspepsia Patients Classified by 3-Dimensional Facial Measurement: A Study Protocol for Placebo-Controlled, Double-Blind, Randomized Trial Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia.Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.Burden of Dyspepsia in Rural and Urban Asia: Author's Reply.Modified chaihu shugan powder for functional dyspepsia: meta-analysis for randomized controlled trial.Effects of GC7101, a Novel Prokinetic Agent on Gastric Motor Function: Ex Vivo Study.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.Current management of functional dyspepsia: impact of Rome III subdivision.The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.Management of functional dyspepsia: state of the art and emerging therapies.Influence of tegaserod on proximal gastric tone and on the perception of gastric distention in functional dyspepsia.Increased Frequency of MEFV Genes in Patients with Epigastric Pain Syndrome.Chinese herbal medicine for functional dyspepsia: systematic review of systematic reviews Lack of effect of antacids on single-dose pharmacokinetics of etoricoxib Asian consensus report on functional dyspepsia Insights into the evaluation and management of dyspepsia: recent developments and new guidelines

P2860

Q24235762-730BD8C9-FF43-4E4D-8BBE-C3E86E56A71E Q26825651-BB93272E-A525-4462-A88D-F05234D90C57 Q33501352-C7A04536-CFE4-42BA-96A2-ADCD960DE55D Q33836928-81880325-CBEA-4C66-B930-F84E3372B26C Q34409166-770C6E9C-6D3D-4F6F-AE99-7A575EE526B4 Q34490922-237CD296-123A-4E26-9FAC-1E5909123C28 Q35885912-AFEBE386-67EE-4D3C-A972-B87FC299A434 Q35885936-D329532D-EFAC-4144-8769-BEBD8A9EB378 Q36300366-B1E660CF-7101-4CAF-B3D1-C14AB8BE5517 Q36337373-84268AC3-931D-4739-871D-E0C0B72E4B2D Q36443725-E795F964-920A-49DC-83AB-0A6F0F2684AF Q36609524-C8E942F3-7A6A-473B-A9C9-ED45D6D6DCBE Q36759762-C23EF2AD-2077-40C2-A6AB-6FA3B7637F10 Q36762648-BEF0851A-A066-4EAA-8375-7CB4D35DB8F2 Q37647335-21B1B179-C971-48EC-98CA-2C1702174872 Q37714702-2F2C749A-EEF0-4D3E-9B53-684C1BFA237D Q37858637-202C68AF-EE9F-4B02-9984-3C1759DEEE44 Q37913063-6717D0BE-C216-4739-B745-2723E5B50ADC Q38026979-A35680FD-40DD-45BD-B430-E993C68A2891 Q38240885-AB2E8341-AF59-420D-9677-A3776315878E Q38378201-B7F2C2DB-C530-4A62-BD48-1EFB397A232B Q38646393-A0C56634-478C-491B-BD4C-DC48B3891B00 Q39411364-3F291E57-79A0-49EC-8D3B-2737D614529C Q39976307-BFE4E857-6DFE-4B3C-8BC3-D7617A9EDA59 Q40031702-9E368D43-8E9A-4794-9105-AE4D63E2861C Q41142747-1FF33754-3D43-4D65-A67E-12FD67677A70 Q41833933-4E740482-5472-4EE9-9661-E684A2AF18C7 Q42371575-82E01AA6-4625-48A7-8E94-2DE323F1CA35 Q42375227-DBCAD8AE-D6A7-4DC1-A604-7264C9B8D40B Q42406690-BCB6E63E-BCE8-4619-A54E-8A65321B6148 Q42548274-D2CCDBA8-7B6B-4103-8A79-0EA880A68BE4 Q47855083-78ECA5AD-9120-4A64-B9DA-087CB7522CB0 Q51388257-39A55D86-9681-47CD-AA14-FC10E67B64F4 Q55102959-99A1FF0E-7A35-464F-B1AB-52645F051964 Q57175888-6229A58D-7A1C-406C-8D80-4C4E61763365 Q57221140-4F9255F2-BC86-4449-A764-0123440A5400 Q57728314-D82AB9C4-E62C-4534-9CCD-2D7A2A4E4578 Q58409793-039C51AB-FCAC-48C3-8BEF-04E416EA0909

P2860

Pharmacological interventions for non-ulcer dyspepsia

http://www.wikidata.org/entity/Q24244245

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Pharmacological interventions for non-ulcer dyspepsia

@ast

Pharmacological interventions for non-ulcer dyspepsia

@en

Pharmacological interventions for non-ulcer dyspepsia

@en-gb

Pharmacological interventions for non-ulcer dyspepsia

@nl

type

label

Pharmacological interventions for non-ulcer dyspepsia

@ast

Pharmacological interventions for non-ulcer dyspepsia

@en

Pharmacological interventions for non-ulcer dyspepsia

@en-gb

Pharmacological interventions for non-ulcer dyspepsia

@nl

prefLabel

Pharmacological interventions for non-ulcer dyspepsia

@ast

Pharmacological interventions for non-ulcer dyspepsia

@en

Pharmacological interventions for non-ulcer dyspepsia

@en-gb

Pharmacological interventions for non-ulcer dyspepsia

@nl

P1433

Q24244245-CBC96641-EC45-4344-AF3B-6CF3C6A6E6E9

P1476

Q24244245-874C3CE8-00E5-4B59-8C8D-ABC3242DACC8

P2093

Q24244245-0C6C790F-3DE3-4261-80E5-13E1743ED76D

Q24244245-30F66FFC-44C6-4C78-888E-09E2D96FED5C

Q24244245-B7E14F00-88B5-431D-B82A-0C54C5E86391

Q24244245-DEA978B2-3920-462F-9FB6-3E4EA6EBAC8B

Q24244245-E56E0243-B242-43C8-BE9A-23561B87FA48

P2860

Q24244245-03914ED0-E3FB-45A7-8A15-5D5D293D9550

Q24244245-0624A551-FC1F-4441-B4FC-18CDD953381B

Q24244245-0DCC0CE9-15D9-49FF-BE67-7318CD98D605

Q24244245-16B41D16-A4B4-4FF9-9180-B28A7F11E90E

Q24244245-170F6D8E-1CB9-41D8-AC96-A02740CA928D

Q24244245-17564B9E-660D-454D-A0AF-F90E6BBCCF10

Q24244245-1B994719-544A-4C0D-A2E8-6F6E9B1541D0

Q24244245-1BB50274-977F-47CD-97AA-63124970C3BA

Q24244245-24F4CC5C-FB51-48F5-AA8D-4467F3901362

Q24244245-2CE8E0E1-E4F6-4F83-ABF2-ED33AF40D3C9

P31

Q24244245-6E523AF5-75C0-4556-9D9D-93DAB306E5C9

Q24244245-b3c5ed21-6c4d-4cfc-af2d-609c28fb1b97

P3181

Q24244245-7CDF92B9-D438-4A1F-A880-374ED93C2F27

P356

Q24244245-F1BB1AE8-07C8-4476-915B-9C3F06A10A0F

P50

Q24244245-1A2A8A47-6044-400F-B594-F246193D8457

P577

Q24244245-BABDA1F9-7DD4-4E95-A1ED-90CEE01DCEA5

P698

Q24244245-E1B6759A-5217-414A-A299-281D8F7F6827

P921

Q24244245-B42338A6-ED98-4AEE-BA45-6A5B08A97C4F

P3181

P356

14651858.CD001960.PUB3

P1433

Cochrane Database of Systematic Reviews

P1476

Pharmacological interventions for non-ulcer dyspepsia

@en

P2093

Brendan Delaney

http://www.w3.org/2001/XMLSchema#string

David Forman

http://www.w3.org/2001/XMLSchema#string

Jonathan J Deeks

http://www.w3.org/2001/XMLSchema#string

Michael Innes

http://www.w3.org/2001/XMLSchema#string

Soo Shelly

http://www.w3.org/2001/XMLSchema#string

P2860

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.

Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.

Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis.

Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.

Dyspepsia in England and Scotland

Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study.

A placebo-controlled trial of itopride in functional dyspepsia.

A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.

Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride)

Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori

P31

scholarly article

P3181

2512948

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD001960.PUB3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17054151

http://www.w3.org/2001/XMLSchema#string

P921